Hubei Jumpcan Pharmaceutical Co., Ltd. (SHSE: 600566)
Health Care · Pharmaceuticals · CN
CN¥24.39
-2.87% today · -11.4% 1Y
Hubei Jumpcan Pharmaceutical Co., Ltd. (SHSE: 600566) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.34B and employs 4,137 people.
Over the last twelve months the share price has lost 11.4%, trading between 21.13 and 29.60.
Tweenvest scores Hubei Jumpcan Pharmaceutical Co., Ltd. across four factors: quality 79/100, value 47/100, growth 31/100, dividend 90/100. Its strongest factor is dividend.
600566 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.34B
- Revenue (TTM)
- $855.50M
- P/E
- 12.90
- EPS
- 1.89
- Dividend yield
- 6.93%
- Beta (5Y)
- 0.08
- 52-week high
- CN¥29.60
- 52-week low
- CN¥21.13
- Avg volume (3M)
- —
- Shares outstanding
- 921.66M
- Employees
- 4,137
- Next earnings
- —
About Hubei Jumpcan Pharmaceutical Co., Ltd.
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
- ISIN
- CNE0000018X6
- Listed since
- Aug 22, 2001
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,249.71 | -0.45% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.79 | +0.94% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.65 | -1.25% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.16% |
Figures last refreshed Aug 18, 2026.